440 related articles for article (PubMed ID: 18156813)
41. Pkhd1
Yang C; Harafuji N; Caldovic L; Yu W; Boddu R; Bhattacharya S; Barseghyan H; Gordish-Dressman H; Foreman O; Bebok Z; Eicher EM; Guay-Woodford LM
J Mol Med (Berl); 2023 Sep; 101(9):1141-1151. PubMed ID: 37584738
[TBL] [Abstract][Full Text] [Related]
42. Polycystic liver and kidney diseases.
Tahvanainen E; Tahvanainen P; Kääriäinen H; Höckerstedt K
Ann Med; 2005; 37(8):546-55. PubMed ID: 16338757
[TBL] [Abstract][Full Text] [Related]
43. PKHD1 mutations in autosomal recessive polycystic kidney disease (ARPKD).
Bergmann C; Senderek J; Küpper F; Schneider F; Dornia C; Windelen E; Eggermann T; Rudnik-Schöneborn S; Kirfel J; Furu L; Onuchic LF; Rossetti S; Harris PC; Somlo S; Guay-Woodford L; Germino GG; Moser M; Büttner R; Zerres K
Hum Mutat; 2004 May; 23(5):453-63. PubMed ID: 15108277
[TBL] [Abstract][Full Text] [Related]
44. Inhibition of PKHD1 may cause S-phase entry via mTOR signaling pathway.
Zheng R; Wang L; Fan J; Zhou Q
Cell Biol Int; 2009 Sep; 33(9):926-33. PubMed ID: 19524688
[TBL] [Abstract][Full Text] [Related]
45. Expression of components of the renin-angiotensin system in autosomal recessive polycystic kidney disease.
Loghman-Adham M; Soto CE; Inagami T; Sotelo-Avila C
J Histochem Cytochem; 2005 Aug; 53(8):979-88. PubMed ID: 15879580
[TBL] [Abstract][Full Text] [Related]
46. Prenatal diagnosis of autosomal recessive polycystic kidney disease by molecular genetic analysis.
Jang DG; Chae H; Shin JC; Park IY; Kim M; Kim Y
J Obstet Gynaecol Res; 2011 Nov; 37(11):1744-7. PubMed ID: 21790888
[TBL] [Abstract][Full Text] [Related]
47. Cystin is required for maintaining fibrocystin (FPC) levels and safeguarding proteome integrity in mouse renal epithelial cells: A mechanistic connection between the kidney defects in cpk mice and human ARPKD.
Zhang YJ; Yang C; Wang W; Harafuji N; Stasiak P; Bell PD; Caldovic L; Sztul E; Guay-Woodford LM; Bebok Z
FASEB J; 2023 Jul; 37(7):e23008. PubMed ID: 37318790
[TBL] [Abstract][Full Text] [Related]
48. Kinesin-2 mediates physical and functional interactions between polycystin-2 and fibrocystin.
Wu Y; Dai XQ; Li Q; Chen CX; Mai W; Hussain Z; Long W; Montalbetti N; Li G; Glynne R; Wang S; Cantiello HF; Wu G; Chen XZ
Hum Mol Genet; 2006 Nov; 15(22):3280-92. PubMed ID: 17008358
[TBL] [Abstract][Full Text] [Related]
49. A complete mutation screen of PKHD1 in autosomal-recessive polycystic kidney disease (ARPKD) pedigrees.
Rossetti S; Torra R; Coto E; Consugar M; Kubly V; Málaga S; Navarro M; El-Youssef M; Torres VE; Harris PC
Kidney Int; 2003 Aug; 64(2):391-403. PubMed ID: 12846734
[TBL] [Abstract][Full Text] [Related]
50. Algorithm for efficient PKHD1 mutation screening in autosomal recessive polycystic kidney disease (ARPKD).
Bergmann C; Küpper F; Dornia C; Schneider F; Senderek J; Zerres K
Hum Mutat; 2005 Mar; 25(3):225-31. PubMed ID: 15706593
[TBL] [Abstract][Full Text] [Related]
51. Molecular genetics of autosomal recessive polycystic kidney disease.
Harris PC; Rossetti S
Mol Genet Metab; 2004 Feb; 81(2):75-85. PubMed ID: 14741187
[TBL] [Abstract][Full Text] [Related]
52. Therapeutic Potential for CFTR Correctors in Autosomal Recessive Polycystic Kidney Disease.
Yanda MK; Tomar V; Cebotaru L
Cell Mol Gastroenterol Hepatol; 2021; 12(5):1517-1529. PubMed ID: 34329764
[TBL] [Abstract][Full Text] [Related]
53. [Autosomal-recessive renal cystic disease and congenital hepatic fibrosis: clinico-anatomic case].
Rostol'tsev KV; Burenkov RA; Kuz'micheva IA
Arkh Patol; 2012; 74(3):57-60. PubMed ID: 22937583
[TBL] [Abstract][Full Text] [Related]
54. Abnormalities in focal adhesion complex formation, regulation, and function in human autosomal recessive polycystic kidney disease epithelial cells.
Israeli S; Amsler K; Zheleznova N; Wilson PD
Am J Physiol Cell Physiol; 2010 Apr; 298(4):C831-46. PubMed ID: 19923420
[TBL] [Abstract][Full Text] [Related]
55. Analysis of missense variants in the PKHD1-gene in patients with autosomal recessive polycystic kidney disease (ARPKD).
Losekoot M; Haarloo C; Ruivenkamp C; White SJ; Breuning MH; Peters DJ
Hum Genet; 2005 Nov; 118(2):185-206. PubMed ID: 16133180
[TBL] [Abstract][Full Text] [Related]
56. Spectrum of mutations in the gene for autosomal recessive polycystic kidney disease (ARPKD/PKHD1).
Bergmann C; Senderek J; Sedlacek B; Pegiazoglou I; Puglia P; Eggermann T; Rudnik-Schöneborn S; Furu L; Onuchic LF; De Baca M; Germino GG; Guay-Woodford L; Somlo S; Moser M; Büttner R; Zerres K
J Am Soc Nephrol; 2003 Jan; 14(1):76-89. PubMed ID: 12506140
[TBL] [Abstract][Full Text] [Related]
57. Predominant Liver Cystic Disease in a New Heterozygotic PKHD1 Variant: A Case Report.
Van Buren JD; Neuman JT; Sidlow R
Am J Case Rep; 2023 Jan; 24():e938507. PubMed ID: 36691356
[TBL] [Abstract][Full Text] [Related]
58. Predominant extrahepatic biliary disease in autosomal recessive polycystic kidney disease: a new association.
Goilav B; Norton KI; Satlin LM; Guay-Woodford L; Chen F; Magid MS; Emre S; Shneider BL
Pediatr Transplant; 2006 May; 10(3):294-8. PubMed ID: 16677351
[TBL] [Abstract][Full Text] [Related]
59. Tissue-specific regulation of the mouse Pkhd1 (ARPKD) gene promoter.
Williams SS; Cobo-Stark P; Hajarnis S; Aboudehen K; Shao X; Richardson JA; Patel V; Igarashi P
Am J Physiol Renal Physiol; 2014 Aug; 307(3):F356-68. PubMed ID: 24899057
[TBL] [Abstract][Full Text] [Related]
60. The autosomal recessive polycystic kidney disease protein is localized to primary cilia, with concentration in the basal body area.
Wang S; Luo Y; Wilson PD; Witman GB; Zhou J
J Am Soc Nephrol; 2004 Mar; 15(3):592-602. PubMed ID: 14978161
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
